HomeCompareRAONF vs GBDC

RAONF vs GBDC: Dividend Comparison 2026

RAONF yields 76.92% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $19.40M in total portfolio value· pulled ahead in Year 8
10 years
RAONF
RAONF
● Live price
76.92%
Share price
$2.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.45M
Annual income
$406,212.55
Full RAONF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — RAONF vs GBDC

📍 GBDC pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRAONFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RAONF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RAONF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAONF
Annual income on $10K today (after 15% tax)
$6,538.46/yr
After 10yr DRIP, annual income (after tax)
$345,280.67/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,637,843.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAONF + GBDC for your $10,000?

RAONF: 50%GBDC: 50%
100% GBDC50/50100% RAONF
Portfolio after 10yr
$11.15M
Annual income
$8,428,473.19/yr
Blended yield
75.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

RAONF
No analyst data
Altman Z
259.5
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAONF buys
0
GBDC buys
0
No recent congressional trades found for RAONF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRAONFGBDC
Forward yield76.92%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$1.45M$20.85M
Annual income after 10y$406,212.55$16,450,733.83
Total dividends collected$1.25M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: RAONF vs GBDC ($10,000, DRIP)

YearRAONF PortfolioRAONF Income/yrGBDC PortfolioGBDC Income/yrGap
1$18,392$7,692.31$12,492$1,791.70+$5.9KRAONF
2$32,902$13,222.36$16,527$3,160.58+$16.4KRAONF
3$57,311$22,106.15$23,588$5,904.90+$33.7KRAONF
4$97,310$35,987.08$37,141$11,901.65+$60.2KRAONF
5$161,228$57,105.82$66,205$26,463.38+$95.0KRAONF
6$260,939$88,425.56$137,452$66,612.65+$123.5KRAONF
7$412,955$133,749.94$342,372$195,298.53+$70.6KRAONF
8← crossover$639,683$197,821.28$1,053,292$686,954.33$413.6KGBDC
9$970,847$286,385.73$4,111,439$2,984,416.95$3.14MGBDC
10$1,445,019$406,212.55$20,849,974$16,450,733.83$19.40MGBDC

RAONF vs GBDC: Complete Analysis 2026

RAONFStock

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Full RAONF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this RAONF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAONF vs SCHDRAONF vs JEPIRAONF vs ORAONF vs KORAONF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.